Figure 1From: The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndromePercentage change from baseline in lipids. * p < 0.05, 12 week versus baseline in the same group; § p < 0.05, combination group versus statin group.Back to article page